Comparative safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation: A network meta-analysis by Yi-Hsin Chan, Shao-Wei Chen, Chih-Yu Chan, Tze-Fan Chao

Get full text

Modified Taiwan Atrial Fibrillation Score for the Prediction of Incident Atrial Fibrillation by Jo-Nan Liao, Jo-Nan Liao, Su-Shen Lim, Su-Shen Lim, Tzeng-Ji Chen, Ta-Chuan Tuan, Ta-Chuan Tuan, Shih-Ann Chen, Shih-Ann Chen, Shih-Ann Chen, Tze-Fan Chao, Tze-Fan Chao

Get full text

Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral Anticoagulants by Jo-Nan Liao, Jo-Nan Liao, Yi-Hsin Chan, Yi-Hsin Chan, Yi-Hsin Chan, Ling Kuo, Ling Kuo, Chuan-Tsai Tsai, Chuan-Tsai Tsai, Su-Shen Lim, Su-Shen Lim, Tze-Fan Chao, Tze-Fan Chao

Get full text

Strategies for the prevention of ischemic stroke in atrial fibrillation in East Asia: clinical features, changes and challenges by Tze-Fan Chao, Eue-Keun Choi, Yutao Guo, Wataru Shimizu, Hung-Fat Tse, Gregory Y.H. Lip

Get full text

The risk of consequent nephropathy following initial weight loss in diabetic patients treated with sodium glucose cotransporter 2 inhibitors by Yi-Hsin Chan, Shao-Wei Chen, Tze-Fan Chao, Yi-Wei Kao, Chien-Ying Huang, Pao-Hsien Chu

Get full text

Distinct atrial remodeling in patients with subclinical atrial fibrillation: Lessons from computed tomographic images by Sung‐Hao Huang, Chao‐Feng Liao, Zu‐Yin Chen, Tze‐Fan Chao, Shih‐Ann Chen, Hsuan‐Ming Tsao

Get full text

Initial eGFR Changes with SGLT2 Inhibitor in Patients With Type 2 Diabetes and Associations With the Risk of Abnormal Serum Potassium Level by Yi‐Wei Kao, Tze‐Fan Chao, Shao‐Wei Chen, Yu‐Wen Cheng, Yi‐Hsin Chan, Pao‐Hsien Chu

Get full text

The impact of weight loss related to risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium–glucose cotransporter 2 inhibitor by Yi-Hsin Chan, Shao-Wei Chen, Tze-Fan Chao, Yi-Wei Kao, Chien-Ying Huang, Pao-Hsien Chu

Get full text

Influenza vaccination and risk of respiratory failure in patients with chronic obstructive pulmonary disease: A nationwide population-based case-cohort study by Hsin-Hui Huang, Su-Jung Chen, Tze-Fan Chao, Chia-Jen Liu, Tzeng-Ji Chen, Pesus Chou, Fu-Der Wang

Get full text

Barriers to stroke prevention in Atrial Fibrillation: Insights from the global anticoagulation Roundtable by Geoffrey D. Barnes, Gregory Piazza, Geoffrey D. Barnes, Tze-Fan Chao, Mario Njeim, Kian Keong Poh, Leandro Zimerman, Gregory Piazza

Get full text

Which dose of apixaban is suitable for Asian patients with atrial fibrillation who have a serum creatinine < 1.5 mg/dL but an estimated glomerular filtration rate < 50 mL/min?... by Chuan-Tsai Tsai, Jo-Nan Liao, Yi-Hsin Chan, Ling Kuo, Chih-Min Liu, Gregory Y.H. Lip, Tze-Fan Chao

Get full text

The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis—a nationwide cohort study by Chuan-Tsai Tsai, Yi-Hsin Chan, Jo-Nan Liao, Tzeng-Ji Chen, Gregory Y. H. Lip, Shih-Ann Chen, Tze-Fan Chao

Get full text

Number of Previous Strokes and the Association With Clinical Outcomes of Patients With Atrial Fibrillation: Longitudinal Data From the GLORIA‐AF Registry by Steven Ho Man Lam, Giulio Francesco Romiti, Bernadette Corica, Tommaso Bucci, Brian Olshansky, Tze‐Fan Chao, Menno V. Huisman, Gregory Y. H. Lip

Get full text

Patterns of pharmacological treatment in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF Registry Phase III by Bernadette Corica, Giulio Francesco Romiti, Giuseppe Boriani, Brian Olshansky, Tze-Fan Chao, Menno V. Huisman, Marco Proietti, Gregory Y. H. Lip, on behalf of the GLORIA-AF Investigators

Get full text

Gender Differences in Patients with Atrial Fibrillation Receiving Oral Anticoagulants by Jo-Nan Liao, Yu-Shan Huang, Chuan-Tsai Tsai, Ling Kuo, Su-Jung Chen, Ta-Chuan Tuan, Tzeng-Ji Chen, Shih-Ann Chen, Tze-Fan Chao

Get full text

Comparisons of Rivaroxaban Following Different Dosage Criteria (ROCKET AF or J‐ROCKET AF Trials) in Asian Patients With Atrial Fibrillation by Yi‐Hsin Chan, Hsin‐Fu Lee, Chun‐Li Wang, Shang‐Hung Chang, Chih‐Hsin Yeh, Tze‐Fan Chao, Yung‐Hsin Yeh, Shih‐Ann Chen, Chi‐Tai Kuo

Get full text

2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation by Tze‐Fan Chao, Boyoung Joung, Yoshihide Takahashi, Toon Wei Lim, Eue‐Keun Choi, Yi‐Hsin Chan, Yutao Guo, Charn Sriratanasathavorn, Seil Oh, Ken Okumura, Gregory Y. H. Lip

Get full text

Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban by Tze-Fan Chao, Yi-Hsin Chan, Pei-Chien Tsai, Hsin-Fu Lee, Shang-Hung Chang, Chi-Tai Kuo, Gregory Y. H. Lip, Shih-Ann Chen, Yung-Hsin Yeh

Get full text

Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial by Alon Eisen, Christian T. Ruff, Eugene Braunwald, Rose A. Hamershock, Basil S. Lewis, Christian Hassager, Tze‐Fan Chao, Jean Yves Le Heuzey, Michele Mercuri, Howard Rutman, Elliott M. Antman, Robert P. Giugliano

Get full text

Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry by Giulio Francesco Romiti, Bernadette Corica, Davide Antonio Mei, Arnaud Bisson, Giuseppe Boriani, Brian Olshansky, Tze-Fan Chao, Menno V. Huisman, Marco Proietti, Gregory Y. H. Lip, on behalf of the GLORIA-AF Investigators

Get full text